These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Upper extremity swelling and hyperpigmentation due to onchocerciasis in an American. Joyce MP; Pearson RD South Med J; 1987 Nov; 80(11):1452-4. PubMed ID: 3686152 [TBL] [Abstract][Full Text] [Related]
65. [Diagnostic image (105). A woman with painful nodules. Infection with O. volvulus]. Kampinga GA; Sprenger HG; de Graeff PA; Rulo HF; de Vries-Hospers HG Ned Tijdschr Geneeskd; 2002 Sep; 146(37):1734. PubMed ID: 12357874 [TBL] [Abstract][Full Text] [Related]
66. Ivermectin: pharmacology and application in dermatology. Dourmishev AL; Dourmishev LA; Schwartz RA Int J Dermatol; 2005 Dec; 44(12):981-8. PubMed ID: 16409259 [TBL] [Abstract][Full Text] [Related]
67. Ocular involvement in patients with onchocerciasis after repeated treatment with ivermectin. Rothova A; Van der Lelij A; Stilma JS; Klaassen-Broekema N; Wilson WR; Barbe RF Am J Ophthalmol; 1990 Jul; 110(1):6-16. PubMed ID: 2368822 [TBL] [Abstract][Full Text] [Related]
68. Onchocerciasis control in regard to PHC/BHS. Samba EM Acta Leiden; 1990; 59(1-2):383-6. PubMed ID: 2378220 [No Abstract] [Full Text] [Related]
69. Tanzania's fight against onchocerciasis. Loewenberg S Lancet; 2008 Nov; 372(9651):1721-2. PubMed ID: 19018612 [No Abstract] [Full Text] [Related]
70. After 70 years of fighting an age-old scourge, onchocerciasis in Uganda, the end is in sight. Katabarwa MN; Lakwo T; Habomugisha P; Unnasch TR; Garms R; Hudson-Davis L; Byamukama E; Khainza A; Ngorok J; Tukahebwa E; Richards FO Int Health; 2018 Mar; 10(suppl_1):i79-i88. PubMed ID: 29471335 [TBL] [Abstract][Full Text] [Related]
71. Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg). Kamgno J; Pion SD; Tejiokem MC; Twum-Danso NA; Thylefors B; Boussinesq M Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):777-85. PubMed ID: 17531279 [TBL] [Abstract][Full Text] [Related]
72. [Crusted scabies (Norwegian scabies) a case report]. Fernández-Tamayo N; Flores-Villa R; Blanco-Aguilar J; Dueñas-Arau Mde L; Peña-Flores Mdel P; Rubio-Calva C; Santos-Marcial E Gac Med Mex; 2006; 142(6):507-10. PubMed ID: 17201114 [TBL] [Abstract][Full Text] [Related]
73. [Chemotherapeutic problems in onchocerciasis]. Rivas Alcalá AR; Ricárdez Esquinca JR Bol Chil Parasitol; 1988; 43(3-4):57-61. PubMed ID: 3077746 [No Abstract] [Full Text] [Related]
74. Onchocerciasis in Canada. Seah SK Can Med Assoc J; 1974 Mar; 110(6):665-8. PubMed ID: 4817212 [TBL] [Abstract][Full Text] [Related]
75. In vivo and in vitro effects of extracts from Cassia aubrevillei in onchocerciasis. Kilian HD; Jahn K; Kraus L; Büttner DW Acta Leiden; 1990; 59(1-2):365-71. PubMed ID: 2378217 [TBL] [Abstract][Full Text] [Related]
76. Onchocerciasis in Tigray. Terranova M; Padovese V; Klaus S; Morrone A Int J Dermatol; 2007 Oct; 46 Suppl 2():39-41. PubMed ID: 17958630 [No Abstract] [Full Text] [Related]
77. [Onchocerciasis in Chiapas. I. Methods and evaluation of the quantitative skin biopsy]. Gómez-Priego A; Ehremberg-Enríquez JP; Ortega-Gutiérrez M; Beltrán-Hernández F Salud Publica Mex; 1978; 20(1):57-65. PubMed ID: 752933 [No Abstract] [Full Text] [Related]
78. Mepacrine--ineffective in onchocerciasis. Kale OO Tropenmed Parasitol; 1980 Sep; 31(3):365-6. PubMed ID: 7445069 [TBL] [Abstract][Full Text] [Related]
79. Possible transplacental transmission of Onchocerca volvulus. Ufomadu GO; Sato Y; Takahashi H Trop Geogr Med; 1990 Jan; 42(1):69-71. PubMed ID: 2260199 [TBL] [Abstract][Full Text] [Related]
80. Detection of Onchocerca volvulus infection in low prevalence areas: a comparison of three diagnostic methods. Boatin BA; Toé L; Alley ES; Nagelkerke NJ; Borsboom G; Habbema JD Parasitology; 2002 Dec; 125(Pt 6):545-52. PubMed ID: 12553573 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]